Skip to Content

Pfizer seeking FDA OK for COVID-19 vaccine booster dose

AP Health Writer

Pfizer is seeking U.S. approval of a booster dose of its two-shot COVID-19 vaccine. The drugmaker announced Wednesday that it has started the approval process for a third dose of its vaccine for all Americans ages 16 and older. The company said it expects to complete its application with the Food and Drug Administration by the end of this week. U.S. health officials last week announced plans to dispense COVID-19 booster shots to all Americans to shore up their protection amid the surging delta variant of the virus. Pfizer’s vaccine received full regulatory approval this week. 

Article Topic Follows: AP National Business

Jump to comments ↓

Author Profile Photo

The Associated Press


News Channel 3-12 is committed to providing a forum for civil and constructive conversation.

Please keep your comments respectful and relevant. You can review our Community Guidelines by clicking here

If you would like to share a story idea, please submit it here.

Skip to content